DECIBEL THERAPEUTICS INC (DBTX) Stock Analyst Earnings Estimates
NASDAQ:DBTX - Nasdaq - US24343R1068 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -100.00% | N/A | N/A 146.92% | N/A 81.67% | ||||||
| EBITDA YoY % growth | -36.39M | -42.31M -16.27% | -34.45M 18.58% | -48.818M -41.71% | -62.495M -28.02% | N/A 0.74% | N/A -19.31% | N/A -22.05% | N/A -1.73% | N/A 50.83% | N/A 125.06% | |
| EBIT YoY % growth | -37.86M | -44.08M -16.43% | -36.09M 18.13% | -50.231M -39.18% | -63.957M -27.33% | N/A 7.92% | N/A -34.41% | N/A -14.83% | N/A -24.44% | N/A 37.78% | N/A 73.19% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.64 | -2.51 4.92% | N/A -15.00% | N/A 5.65% | N/A 36.29% | N/A 11.82% | N/A 65.33% | N/A 125.00% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.79 -22.72% | -0.83 -31.14% | -0.79 -48.19% | -0.84 -14.58% | -0.80 -1.30% | -0.43 48.15% |
| Revenue Q2Q % growth | 10.2M | |||||
| EBITDA Q2Q % growth | -15.912M -4.27% | -18.87M -25.60% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.682M -26.50% | -21.733M -31.83% | -22.347M -58.25% | -25.18M -32.24% | -25.895M -25.21% | -15.416M 29.07% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.73 -7.35% | -0.56 | -0.17 | -30.24% |
| Q1 2023 Q2Q % growth | -0.53 5.36% | -0.62 | 0.09 | 13.85% |
| Q4 2022 Q2Q % growth | -0.63 -28.57% | -0.41 | -0.22 | -54.48% |
| Q3 2022 Q2Q % growth | -0.64 -8.47% | -0.70 | 0.06 | 8.53% |
| Q2 2022 Q2Q % growth | -0.68 -44.68% | -0.58 | -0.10 | -17.10% |
| Q1 2022 Q2Q % growth | -0.56 48.62% | -0.57 | 0.01 | 1.14% |
| Q4 2021 Q2Q % growth | -0.49 | -0.48 | -0.01 | -1.14% |
| Q3 2021 Q2Q % growth | -0.59 | -0.44 | -0.15 | -33.96% |
| Q2 2021 Q2Q % growth | -0.47 | -0.38 | -0.09 | -23.95% |
| Q1 2021 Q2Q % growth | -1.09 | -0.55 | -0.54 | -98.26% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 3.536M | -3.536M | -100.00% | |
| Q1 2023 Q2Q % growth | 2.231M | -2.231M | -100.00% | |
| Q4 2022 Q2Q % growth | 7.65M | -7.65M | -100.00% | |
| Q4 2021 Q2Q % growth | 2.55M | -2.55M | -100.00% | |
| Q2 2021 Q2Q % growth | 2.635M | -2.635M | -100.00% | |
| Q1 2021 Q2Q % growth | 1.976M | -1.976M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -29.92% | -32.49% | -11.01% |
| Revenue | N/A | -100% | -100% | -100% |